首页 › 克罗恩病 › 俄克拉荷马州 › Oklahoma City
Oklahoma City OK 克罗恩病临床试验
7项针对 克罗恩病的研究正在 Oklahoma City及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
招募中3 期
- Digestive Disease Specialists Inc. ( Site 5117), Oklahoma City
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
招募中2 期
- Digestive Disease Specialists - Oklahoma /ID# 265901, Oklahoma City
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Digestive Disease Specialists Inc, Oklahoma City
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
招募中4 期
- Digestive Disease Specialists, Inc., Oklahoma City
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
招募中3 期
- Digestive Disease Specialists Inc, Oklahoma City
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
招募中3 期
- The University of Oklahoma Health Sciences Center, Oklahoma City
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
招募中3 期
- The University of Oklahoma Health Sciences Center, Oklahoma City
其他城市的 克罗恩病试验
- New York City, NY35 项研究
- Boston, MA19 项研究
- Miami, FL19 项研究
- Cleveland, OH19 项研究
- St. Louis, MO19 项研究
- Tyler, TX17 项研究
- Houston, TX17 项研究
- Orlando, FL17 项研究
- Atlanta, GA17 项研究
- San Antonio, TX15 项研究
- San Diego, CA15 项研究
- Los Angeles, CA15 项研究
Oklahoma City的其他研究
- 非小细胞肺癌28 项研究
- 卵巢癌28 项研究
- 子宫内膜癌25 项研究
- 结直肠癌22 项研究
- 前列腺癌21 项研究
- 肺癌19 项研究
- 乳腺癌17 项研究
- 转移性癌症16 项研究
- 癌症（所有类型）14 项研究
- 急性髓系白血病14 项研究
- 头颈鳞状细胞癌13 项研究
- 膀胱癌11 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。